Shots:
AI is widely used in drug discovery and clinical research to find innovative cures for several debilitating conditions with unmet healthcare needs
Most of the AI architecture employs deep learning that requires extensive training data sets to produce reliable predictive models
Today, at PharmaShots, we have Adityo Prakash, CEO of Verseon, addressing the challenges…
Shots:
Marisa Cruz, MD, and Chief Medical Officer at Empatica, exchanged thoughts with PharmaShots on the revolutionary Empatica Health Monitoring Platform (EHMP)
Approved by the FDA in Nov’2022, EHMP leverages a cloud-based online portal to collect continuous and seamless physiological data from home and clinical setting
While conversing in great depth about Empatica’s EmbracePlus smartwatch,…
Shots:
Ahsan spoke about the US FDA acceptance for Priority Review of sBLAs for PADCEV and KEYTRUDA to treat patients with LA/mUC who are not eligible to receive cisplatin-containing CT
He also talked about the study design and outcomes from the P-Ib/II (EV-103) clinical trial that supported the sBLA. The results from Dose Escalation/Cohort A…
Shots:
Martin gave a detailed view of the newly launched Honey Analytics module associated with the Trialbee Honey™ platform
He also talked about the how Trialbee Honey platform will help in the screening and recruiting of patients specifically in remote areas
The interview gives a profound understanding of how Trialbee is developing real-time monitoring modules…

